Rice bioengineers shed light on dosing challenges for cancer immunotherapy
A team of Rice bioengineers has developed a mathematical model that clarifies why interleukin-12 ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses effectiveness over time when used as an immunotherapeutic.
Rep. Dan Crenshaw hosts leading Rice bioengineer at health care innovation summit
Rice bioengineer Omid Veiseh joined U.S. Rep. Dan Crenshaw, R-Texas, in conversation at Crenshaw’s annual event showcasing health care innovation.
Cancer Bioengineering Collaborative hosts kickoff event, awards first round of seed grants
Leaders and researchers from Rice and the University of Texas MD Anderson Cancer Center came together this month to celebrate the launch of the Cancer Bioengineering Collaborative, first announced earlier this summer.
Newborn and maternal health experts, innovators and community leaders from around the world gathered at the inaugural “Innovation for Day One” conference hosted by the Rice360 Institute for Global Health Technologies. Conference attendees convened to take collective action on solving one of the most pressing global health challenges: improving maternal and newborn health in resource-limited settings.
Rice has launched RBL LLC, a pioneering biotech venture creation studio designed to rapidly build companies based on lifesaving medical technologies developed out of the Rice Biotech Launch Pad.
Rice bioengineers awarded $3.4M for project to end polio
Rice bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against polio into the combination vaccine that protects against five common and dangerous childhood diseases.
Rice is part of multiuniversity research team that has secured $34.9 million from ARPA-H to accelerate the development of a bioelectronic implant designed to revolutionize treatment for obesity and Type 2 diabetes, improving patient experience and outcomes while reducing the development and manufacturing costs.
Rice student team takes top prize in national competition with innovative medical device
A team of Rice engineering students was awarded the top prize in a prestigious national design competition for its innovative medical device for urological care.
Rice and Baylor College of Medicine have received $2.8 million from the NIH for research on reducing inflammation and lung damage in acute respiratory distress syndrome patients.
Rice360 inaugurates conference on newborn, maternal health care innovation
Rice360 will host the first edition of Innovation for Day One Sept. 25-27.
Rice and MD Anderson launch initiative to advance cancer-focused operations research
Rice and the University of Texas MD Anderson Cancer Center today announced the launch of the Center for Operations Research in Cancer, a joint initiative to solve complex challenges in cancer care using data science to make better operational decisions.
Rice lab develops protein assembly road map for gas vesicles
Rice bioengineers developed a road map for the protein-protein interactions that give rise to gas vesicles, naturally occurring nanobubbles with potential use in biomedical applications.
Rice bioengineers develop lotus leaf-inspired system to advance study of cancer cell clusters
Rice bioengineers have harnessed the lotus effect to develop a system for culturing cancer cell clusters that can shed light on hard-to-study tumor properties. The new zinc oxide-based culturing surface mimics the lotus leaf surface structure, providing a highly tunable platform for the high-throughput generation of three-dimensional nanoscale tumor models.
Engineering design interns from Rice, Africa team up to tackle real-world global health problems
Rice’s global health engineering design internship program wrapped up its summer 2024 session with a showcase event featuring collaborative student projects.
A Rice-led multi-institutional research collaboration has won an award of up to $18 million over five years from the Advanced Research Projects Agency for Health (ARPA-H) to develop and validate a new system for improving tumor removal accuracy for two types of cancer: breast, and head and neck cancer.
